- Home
- KDP vs SWKH Comparison
KDP vs SWKH Comparison
Compare KDP & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KDP
- SWKH
- Stock Information
- Founded
- KDP 1981
- SWKH 1996
- Country
- KDP United States
- SWKH United States
- Employees
- KDP N/A
- SWKH N/A
- Industry
- KDP Beverages (Production/Distribution)
- SWKH Diversified Financial Services
- Sector
- KDP Consumer Staples
- SWKH Finance
- Exchange
- KDP Nasdaq
- SWKH Nasdaq
- Market Cap
- KDP N/A
- SWKH 173.6M
- IPO Year
- KDP 1993
- SWKH 1999
- Fundamental
- Price
- KDP $32.56
- SWKH $14.13
- Analyst Decision
- KDP Strong Buy
- SWKH Strong Buy
- Analyst Count
- KDP 15
- SWKH 1
- Target Price
- KDP $39.33
- SWKH $18.00
- AVG Volume (30 Days)
- KDP 10.5M
- SWKH 17.9K
- Earning Date
- KDP 07-24-2025
- SWKH 05-15-2025
- Dividend Yield
- KDP 2.83%
- SWKH N/A
- EPS Growth
- KDP N/A
- SWKH 51.50
- EPS
- KDP 1.10
- SWKH 1.41
- Revenue
- KDP $15,518,000,000.00
- SWKH $34,906,000.00
- Revenue This Year
- KDP $6.44
- SWKH $52.93
- Revenue Next Year
- KDP $3.98
- SWKH N/A
- P/E Ratio
- KDP $29.63
- SWKH $10.14
- Revenue Growth
- KDP 3.94
- SWKH 18.02
- 52 Week Low
- KDP $30.12
- SWKH $12.00
- 52 Week High
- KDP $38.28
- SWKH $16.24
- Technical
- Relative Strength Index (RSI)
- KDP 38.29
- SWKH 52.64
- Support Level
- KDP $32.69
- SWKH $13.86
- Resistance Level
- KDP $33.22
- SWKH $14.48
- Average True Range (ATR)
- KDP 0.48
- SWKH 0.35
- MACD
- KDP -0.04
- SWKH -0.00
- Stochastic Oscillator
- KDP 5.08
- SWKH 66.39
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.